Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Industry / Jordan

Biologics: New Area For Investment

January 2010 | Industry Trend Analysis

According to the Jordanian Food and Drug Administration (JFDA), domestic drugmakers in the country are applying for permission to begin manufacturing biologics. As yet, no licences have been issued, meaning that all drug production in Jordan remains for pharmaceuticals only.

To read the full article, please sign in or take a free trial.

Middle East & Africa InsightMiddle East & Africa Channels Middle East & Africa Countries